Lycia Therapeutics Closes Upsized IPO; Underwriters Exercise Full Option
Lycia Therapeutics said it closed its upsized initial public offering and that underwriters fully exercised their option to purchase additional shares.
Story updates
08:14:54 PM UTC
SquawkNews
Lycia Therapeutics closed its upsized IPO of 20,286,000 shares at $18.00 per share, including the full over-allotment, for aggregate gross proceeds of approximately $365.1M.Material DetailsContext by AI AnalystThis is an early capital formation milestone following Lycia’s Nasdaq debut, confirming i…
08:21:19 PM UTC
SquawkNews
Lycia Therapeutics Raises $365.1 Million in Upsized IPO Lycia Therapeutics closed its upsized IP